Core Viewpoint - The report outlines the verification opinions regarding the listing and circulation of strategic placement restricted shares of Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. following its initial public offering on the Sci-Tech Innovation Board [1][5]. Summary by Sections 1. Type of Restricted Shares - The company issued 91,680,000 shares during its IPO, with a total share capital of 366,680,000 shares post-IPO. The restricted shares amount to 2,639,915 shares, representing 0.7200% of the total share capital, with a lock-up period of 24 months starting from June 20, 2023 [1][2]. 2. Changes in Share Capital - Since the formation of the restricted shares, there have been no changes in the company's share capital due to profit distribution or capital reserve transfers [2]. 3. Commitments Related to Restricted Shares - The shareholder, Haitong Innovation Securities Investment Co., Ltd., has committed to a lock-up period of 24 months from the IPO date. After the lock-up period, any reduction in shareholding will comply with the relevant regulations of the China Securities Regulatory Commission and the Shanghai Stock Exchange [2][3]. 4. Listing and Circulation of Restricted Shares - The restricted shares will be listed and available for circulation on June 20, 2025. The total number of shares for circulation is 2,639,915, which is the entire amount of strategic placement shares [3][4]. 5. Verification Opinions from the Sponsor - The sponsor, Guotai Junan Securities Co., Ltd., confirms that all commitments made by the restricted share shareholders have been strictly adhered to, and the listing and circulation of the restricted shares comply with relevant regulations [4][5].

Group 1 - The core viewpoint of the article is that Citic Securities has conducted a thorough review of Zhejiang Xin'an Chemical Group Co., Ltd.'s issuance of restricted shares to specific investors, confirming compliance with relevant regulations and the successful completion of the share registration process [1][5] - The company issued a total of 203,850,509 shares to 13 specific investors, increasing its total share capital from 1,145,746,540 shares to 1,349,597,049 shares [1][2] - The newly issued shares are subject to a lock-up period of 18 months, with the earliest date for trading being June 17, 2024 [2][3] Group 2 - Since the formation of the restricted shares, there have been no changes in the company's share capital due to profit distribution or capital reserve transfers [2] - The specific investors have committed to not transferring their shares for 18 months following the issuance, and this commitment extends to any shares derived from stock dividends or capital increases [2][5] - The total number of restricted shares that will be listed for trading is 56,625,141, which represents 4.20% of the company's total shares [3][4]

国泰海通证券股份有限公司 关于宁波利安科技股份有限公司 首次公开发行部分限售股上市流通的核查意见 国泰海通证券股份有限公司（以下简称"保荐机构"）作为宁波利安科技股 份有限公司（以下简称"利安科技"或"公司"）首次公开发行股票并创业板上 市及持续督导的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券 交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业 《深圳证券交易所上市公司自律监管指引第 13 号——保荐 板上市公司规范运作》 业务》等法律法规的相关规定，对宁波利安科技股份有限公司首次公开发行部分 限售股上市流通事项进行了核查，核查情况及核查意见如下： 一、本次上市流通的限售股类型 中国证券监督管理委员会于 2024 年 1 月 11 日出具《关于同意宁波利安科技 股份有限公司首次公开发行股票注册的批复》 （证监许可202453 号），同意公司 首次公开发行股票的注册申请。公司首次向社会公开发行人民币普通股（A 股） 完成后总股本为 56,237,600 股，其中有限售条件流通股 42,177,600 股，占发行后 总股本的比例为 75%，无限售条件流通股 14,060,00 ...

民生证券股份有限公司（以下简称"民生证券"或"保荐机构"）作为浙江双 元科技股份有限公司（以下简称"双元科技"或"公司"）首次公开发行股票并在 科创板上市持续督导期间的保荐机构，根据《证券发行上市保荐业务管理办法》 《上海证券交易所科创板股票上市规则》等有关法律法规和规范性文件的要求， 对双元科技首次公开发行战略配售限售股上市流通的事项进行了核查，具体情 况如下： 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2023 年 4 月 复》（证监许可2023803 号），公司获准向社会公开发行人民币普通股（A 股） 股票 1,478.5700 万股，并于 2023 年 6 月 8 日在上海证券交易所科创板上市，发 行完成后公司总股本为 5,914.2700 万股，其中有限售条件流通股 4,570.3190 万 股，无限售条件流通股 1,343.9510 万股。 本次上市流通的限售股为公司首次公开发行战略配售限售股，涉及限售股 股东数量为 1 名，限售期为自公司股票上市之日起 24 个月，该限售股股东对应 的限售股份数量为 476,644 股，占公司股本总数的 0.81%，该限售股将于 2025 年 6 ...

Core Viewpoint - The report outlines the verification opinion of Guoyuan Securities regarding the listing and circulation of restricted shares for Anhui Rongzhi Rixin Technology Co., Ltd. after a specific issuance of A-shares to designated investors, confirming compliance with relevant regulations and the commitment of shareholders [1][5]. Group 1: Restricted Shares Issuance - The company has received approval for the issuance of restricted shares, increasing its total share capital from 81,626,048 shares to 87,427,353 shares, with 5,801,305 shares being restricted and 5,076,141 shares set to be listed for circulation [1][2]. - The restricted shares have a lock-up period of 6 months from the end of the issuance, involving 15 shareholders [1][3]. Group 2: Shareholder Commitments - Shareholders of the restricted shares have committed to not transferring their shares during the 6-month lock-up period, and they have adhered to this commitment without any breaches affecting the listing [3][4]. Group 3: Listing Details - A total of 5,076,141 restricted shares will be listed for circulation, representing 5.81% of the company's total share capital, with the listing date set for May 19, 2025 [4][5]. - The detailed list of shareholders holding restricted shares includes various investment funds and asset management companies [4]. Group 4: Verification Opinion - Guoyuan Securities has concluded that the application for the listing of restricted shares complies with all relevant laws and regulations, and the information disclosed by the company is accurate and complete [5].